These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3420563)

  • 1. Pulmonary Mycobacterium kansasii infection successfully treated with a regimen containing erythromycin.
    Guest PJ; Britton MG; Grundy HC; Yates MD
    Thorax; 1988 Jun; 43(6):488-9. PubMed ID: 3420563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis.
    Evans SA; Colville A; Evans AJ; Crisp AJ; Johnston ID
    Thorax; 1996 Dec; 51(12):1248-52. PubMed ID: 8994524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous Mycobacterium kansasii infection--treatment with erythromycin.
    Groves RW; Newton JA; Hay RJ
    Clin Exp Dermatol; 1991 Jul; 16(4):300-2. PubMed ID: 1794177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response.
    Banks J; Hunter AM; Campbell IA; Jenkins PA; Smith AP
    Thorax; 1983 Apr; 38(4):271-4. PubMed ID: 6867979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acquired rifampicin resistance during M. kansasii infection in a patient with AIDS].
    Dautzenberg B; Antoun F; Truffot C
    Rev Mal Respir; 1992; 9(4):464-6. PubMed ID: 1509191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of pulmonary Mycobacterium kansasii infection with pleural effusion, distinguished from pulmonary tuberculosis].
    Kimura Y; Kurosawa T; Hosaka K
    Kekkaku; 2014 Sep; 89(9):737-41. PubMed ID: 25730945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of multidrug-resistant Mycobacterium fortuitum during treatment.
    Martin ML; Dall L
    Chest; 1984 Mar; 85(3):440-1. PubMed ID: 6697803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience.
    Lillo M; Orengo S; Cernoch P; Harris RL
    Rev Infect Dis; 1990; 12(5):760-7. PubMed ID: 2237115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary
    Padmapriyadarsini C; Nair D; Gomathi NS; Velayudham B
    Indian J Med Microbiol; 2016; 34(4):516-519. PubMed ID: 27934834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis.
    Al Jarad N; Demertzis P; Jones DJ; Barnes NC; Rudd RM; Gaya H; Wedzicha JA; Hughes DT; Empey DW
    Thorax; 1996 Feb; 51(2):137-9. PubMed ID: 8711643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months' chemotherapy.
    Campbell IA
    Tuber Lung Dis; 1995 Dec; 76(6):583. PubMed ID: 8593385
    [No Abstract]   [Full Text] [Related]  

  • 12. Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii.
    Ahn CH; Lowell JR; Ahn SS; Ahn SI; Hurst GA
    Am Rev Respir Dis; 1983 Dec; 128(6):1048-50. PubMed ID: 6650978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary infection with M. kansasii in a renal transplant patient.
    Cruz N; Ramírez-Muxó O; Bermúdez RH; Santiago-Delpín EA
    Nephron; 1980; 26(4):187-8. PubMed ID: 7001262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-course chemotherapy for mycobacteriosis kansasii?
    Schraufnagel DE; Leech JA; Schraufnagel MN; Pollak B
    Can Med Assoc J; 1984 Jan; 130(1):34-8. PubMed ID: 6418368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium kansasii pulmonary infection in patients with AIDS: spectrum of chest radiographic findings.
    Fishman JE; Schwartz DS; Sais GJ
    Radiology; 1997 Jul; 204(1):171-5. PubMed ID: 9205241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium kansasii pulmonary diseases in Korea.
    Yim JJ; Park YK; Lew WJ; Bai GH; Han SK; Shim YS
    J Korean Med Sci; 2005 Dec; 20(6):957-60. PubMed ID: 16361804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ofloxacin in the treatment of pulmonary changes caused by Mycobacterium avium and Mycobacterium xenopii].
    Zwoliński J; Gałazka J
    Pneumonol Alergol Pol; 1992; 60(5-6):70-3. PubMed ID: 1290992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013.
    Morimoto K; Hasegawa N; Izumi K; Namkoong H; Uchimura K; Yoshiyama T; Hoshino Y; Kurashima A; Sokunaga J; Shibuya S; Shimojima M; Ato M; Mitarai S
    Ann Am Thorac Soc; 2017 Jan; 14(1):49-56. PubMed ID: 27788025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYCOBACTERIUM KANSASII AS INFECTING AGENT IN A CASE OF PULMONARY DISEASE--A CASE REPORT.
    STRITCH J; GALLEN C
    J Ir Med Assoc; 1963 Nov; 53():159-60. PubMed ID: 14080838
    [No Abstract]   [Full Text] [Related]  

  • 20. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society.
    Thorax; 1994 May; 49(5):442-5. PubMed ID: 8016763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.